EODData

FRA, TCE2: Celldex Therapeutics Inc

29 May 2026
LAST:

26.84

CHANGE:
 0.05
OPEN:
26.84
HIGH:
26.84
ASK:
0.00
VOLUME:
0
CHG(%):
0.19
PREV:
26.89
LOW:
26.84
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 May 2626.8426.8426.8426.840
28 May 2626.8926.8926.8926.890
27 May 2626.1426.1426.1426.140
26 May 2626.0426.0426.0426.040
25 May 2626.0026.0026.0026.000
22 May 2625.9525.9525.9525.950
21 May 2626.2026.2026.0426.040
20 May 2625.6225.6225.6225.620
19 May 2625.5625.5625.5625.560
18 May 2626.5726.5726.5726.570

PROFILE

Name:Celldex Therapeutics Inc
About:Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:Perryville III Building, Hampton, NJ, United States, 08827
Website:https://www.celldex.com
ISIN:US15117B2025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-9.31 
Forward P/E:-13.18 
PEG Ratio:-0.16 
Price to Sales:582.93 
Price to Book:2.98 
Operating Margin:-98.59 
Return on Assets:-0.22 
Return on Equity:-0.32 
Revenue:2.21M 
Shares:66.41M 
Market Cap:1.782B 

TECHNICAL INDICATORS

MA5:26.381.7%
MA10:26.172.6%
MA20:26.900.2%
MA50:27.141.1%
MA100:24.738.5%
MA200:22.9117.1%
STO9:96.24 
STO14:67.37
RSI14:35.59 
WPR14:-32.63
MTM14:-0.22
ROC14:-0.01 
ATR:0.41 
Week High:26.890.2%
Week Low:25.953.4%
Month High:28.747.1%
Month Low:25.5617.1%
Year High:29.228.9%
Year Low:16.8259.6%
Volatility:8.58 

RECENT SPLITS

Date Ratio
11 Feb 20191-15